Sort Results:
List of Materials
 |
First-In-Man - risk assessmentThe example of TeGenero first-in-man case study was used to explore the usability of systems theoretic accident modeling and processes (STAMP) to create control structure of selected critical points in drug development, approval and... |
ARETE-ZOE, LLC Presenter: Veronika Valdova |
|
Funding Academic Drug DiscoveryThe NIH supports drug discovery and development for nervous system disorders through a variety of programs. Some provide funding through grants or cooperative agreements to support specific stages of research and development, for particular disease... |
NINDS Office of Translational Research Presenter: Rebecca Farkas, Ph.D. |
 |
Generic Pharmaceutical Drug Solutions GuideAgilent Technologies delivers unique, comprehensive solutions based on industry-leading technology, enabling optimal resource utilization so you can improve productivity and be first to market. |
Agilent Technologies Presenter: Agilent Technologies |
|
Genotoxic Impurities PrimerA synopsis of the regulatory requirements associated with genotoxins, as well as recommendations for their implementation. An overview of relevant analytical instrumentation with useful references to valuable scientific publications. |
Agilent Technologies Presenter: Agilent Technologies |
|
Global Pharma Primer, Syllabus and Road MapThe material included in these modules serves many interests by facilitating understanding of construct, dynamics, and influences affecting regulatory policies and corporate decision-making that ultimately determine access, availability, and... |
ARETE-ZOE, LLC Presenter: ARETE-ZOE |
|
High Performance Capillary ElectrophoresisPrimer: 1. Principles of capillary electrophoresis 2. Modes of operation 3. Instrumentation 4. Practical operation and method development |
Agilent Technologies Presenter: Agilent Technologies |
|
Introduction to Drug Discovery ResearchA lecture discussing the current status, historical perspective and the future challenges of Drug Discovery and Development. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Takashi Tsukamoto, Ph.D. |
|
Molecular Subtypes in Glioblastoma Multiforme: Integrated Analysis Using Agilent GeneSpring and Mass Profi ler Professional Multi-Omics SoftwareAgilent GeneSpring and Mass Profi ler Professional (MPP) software was used to perform integrated multi-omics analysis of mRNA expression, miRNA expression, protein expression, and copy number aberration (CNA) associated with glioblastoma multiforme... |
Agilent Technologies Presenter: D. Renu, P. Aggarwal, S. Cherukuri, P. Tata, V. Bhat, C. Livi, M. Rosenberg, M. Al-Gizawiy, K. Schmainda, S. Mirza |
|
NeuroTranslational Drug Discovery ProgramLearn more about the Brain Science Institute NeuroTranslational Drug Discovery Program at Johns Hopkins. This presentation explains how the program got its start, the mission, the staff, the capabilities and future plans. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Barbara Slusher, Ph.D. |
|
Pharmaceutical Applications Compendium Purity and Impurity AnalysisCost-effective methods for purity and impurity analysis, reducing analysis time and solvent consumption while remaining compliant with pharmacopeia guidelines. |
Agilent Technologies Presenter: Agilent Technologies |